Ann Kinworthy
Gerontology · Montgomery, OHNPI 1891177341
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,343 of the $5,373 with a category attached, or 80.8%. 22 manufacturers reported payments, led by Medtronic at 29.5% of the total. Among gerontology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $33.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AOP Health US, LLC$714
- Boston Scientific$549
- Johnson & Johnson$369
- Biosense Webster, Inc.$343
- Pfizer$303
- plus $2K from 16 others
What the payments were for
- Travel & lodging$1,02919%
- Food & beverage$4,34381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $1,583 |
| AOP Health US, LLC | 2 | $714 |
| Boston Scientific | 21 | $549 |
| Johnson & Johnson | 25 | $369 |
| Biosense Webster, Inc. | 3 | $343 |
| Pfizer | 16 | $303 |
| Bayer | 13 | $264 |
| Novartis | 19 | $228 |
| Boehringer Ingelheim | 12 | $204 |
| Edwards Lifesciences | 5 | $155 |
| Abbott | 2 | $141 |
| AstraZeneca | 5 | $86 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $77 |
| Merck | 4 | $66 |
| Amgen | 5 | $65 |
| Novo Nordisk | 3 | $53 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Atricure, Inc. | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Bridgebio Pharma, Inc. | 2 | $29 |
| Cardiva Medical, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rapiblyk$1,427
- Micra$545
- Carto 3$249
- EMBLEM MRI S-ICD$111
- ENSITE PRECISION$109
How this compares
$5,373 in reported general payments places this provider in the 95th percentile of 361 gerontology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 524 | $580,661 |
| XareltoRivaroxaban | 213 | $228,898 |
| EntrestoSacubitril/Valsartan | 87 | $82,339 |
| FarxigaDapagliflozin Propanediol | 56 | $42,039 |
| Repatha SureclickEvolocumab | 34 | $29,558 |
| JardianceEmpagliflozin | 24 | $27,409 |
| VascepaIcosapent Ethyl | 17 | $12,011 |
| Ranolazine ErRanolazine | 53 | $6,362 |
| Flecainide Acetate | 86 | $6,170 |
| Metoprolol Succinate | 395 | $5,137 |
| Amiodarone Hcl | 145 | $3,168 |
| Atorvastatin Calcium | 360 | $2,866 |
| Valsartan | 85 | $2,487 |
| SotalolSotalol Hcl | 116 | $2,218 |
| ClopidogrelClopidogrel Bisulfate | 285 | $2,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $303 | $580,661524 claims |
| Johnson & JohnsonXarelto | $369 | $228,898213 claims |
| NovartisEntresto | $228 | $82,33987 claims |
| AstraZenecaFarxiga | $86 | $42,03956 claims |
| Boehringer IngelheimJardiance | $204 | $27,40924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 361 gerontology providers in Ohio.
Other gerontology in Montgomery
- Kelly BoggsMontgomery$3K
- Natalee ReifMontgomery$2K
- Rohan OttMontgomery$2K
- Elizabeth WeaverColumbus$176K
- Jacqueline GrazianiLorain$44K
- Diana SutherlandCincinnati$32K
- Latonya ForeWestlake$32K
- John ShinnCincinnati$26K
- Rebecca BowmanWarren$20K
- Sarah JohnsonColumbus$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.